An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasWilliam D. Travis, Dominique Valeyre, Harold R. Collard et al.|American Journal of Respiratory and Critical Care Medicine|2013Cited by 4.3k
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W. Noble, Talmadge E. King, Carlo Albera et al.|European Respiratory Journal|2015Cited by 462
Identifying an Inciting Antigen Is Associated With Improved Survival in Patients With Chronic Hypersensitivity PneumonitisEvans R. Fernández Pérez, Kevin K. Brown, Jeffrey J. Swigris et al.|CHEST Journal|2013Cited by 394
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D. Nathan, Paul W. Noble, Carlo Albera et al.|The Lancet Respiratory Medicine|2016Cited by 331
Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetaseJoshua J. Solomon, Kevin K. Brown, Jeffrey J. Swigris|Jornal Brasileiro de Pneumologia|2011Cited by 324